Gabriel M. Cohn

Gabriel M Cohn, MD, MBA, FACMG, FACOG

Dr. Gabriel Cohn is a licensed, board-certified Clinical Geneticist and Obstetrician Gynecologist with more than 30 years of experience in academic medicine and the biotechnology industry and has contributed to the development of multiple therapeutics for the treatment of rare genetic disorders.

Dr. Cohn serves as both the Chief Medical Officer (CMO) at iECURE, a biotech company developing gene editing therapies for rare genetic diseases (currently focused on ornithine transcarbamylase deficiency) ,  and also serves as the Executive Director at the Rosenau Family Research Foundation (RFRF), a 501 (c)(3), private family foundation dedicated to Improving the lives of patients impacted by Krabbe disease and Cystic Fibrosis through research funding and disease advocacy.

Dr. Cohn previously served as the CMO of Homology Medicines where he led the company’s Phase 1/2 gene therapy and gene editing clinical programs in PKU and MPSII. Prior to that, he was Vice President of Clinical Development at AVROBIO, where he led the ex-vivo gene therapy program for Gaucher disease and Pompe disease, and had served in various medical and clinical executive leadership roles at OvaScience and Shire. Since 2017, he has supported and led the successful IND and CTA submissions across five different cell, gene therapy, and gene editing platforms and indications for both adults and children.

Prior to transitioning into industry Dr. Cohn was the first Chief of Clinical and Reproductive Genetics and Medical Director, Genetic Service at Baystate Medical Center and was an Assistant Professor at Tufts University School of Medicine. During over 15 years of academic practice, he and his service provided genetics medicine care to thousands of patients and their families in the areas of prenatal genetics, pediatric genetics, adult genetics, cancer genetics, and genetic therapeutics and was active in translational and clinical research. As an obstetrician-gynecologist he taught and supervised residents and medical students in the management of thousands of patients in the clinic, on labor and delivery, in the operating room, and in the delivery room.

Dr. Cohn is a Fellow of the American College of Genetics and Genomics (ACMG) and the American College of Obstetrics and Gynecology (ACOG), is author of over 100 peer-reviewed publications, chapters, and abstracts, and has received numerous teaching awards. He earned his M.D. from SUNY Health Science Center (Upstate) at Syracuse and an MBA from the Isenberg School of Management at the University of Massachusetts Amherst. Amherst, MA. He completed a residency in Obstetrics & Gynecology at SUNY HSC at Syracuse, NY and a fellowship in Medical Genetics at the National Institutes of Health in Bethesda, MD.